SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001058217-02-000221
Filing Date
2002-09-04
Accepted
2002-09-04 10:37:31
Documents
1
Group Members
DOUGLAS A. HIRSCHSENECA CAPITAL ADVISORS, LLCSENECA CAPITAL II, L.P.SENECA CAPITAL INTERNATIONAL, LTD.SENECA CAPITAL INVESTMENTS, LLCSENECA CAPITAL, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G lynxtherap-seneca13g20625.txt SC 13G 33625
  Complete submission text file 0001058217-02-000221.txt   35916
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45862 | Film No.: 02755906
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 830 THIRD AVE 14TH FL NEW YORK NY 10022
Business Address 830 THIRD AVE 14TH FL NEW YORK NY 10022 2123711300
SENECA CAPITAL ADVISORS LLC (Filed by) CIK: 0001041078 (see all company filings)

IRS No.: 043024178 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 0000